Olean man sentenced to 3-9 years for hit-and-run death
Breaking News
KELLEN M. QUIGLEY kquigley@oleantimesherald.com 
August 27, 2025
OLEAN — An Olean man has been sentenced to three to nine years in state prison for a 2023 hit-and-run incident on Seneca Avenue that resulted in a wom...
Celltrion presents post hoc analysis of LIBERTY studies of ZYMFENTRA®â€¯ (infliximab-dyyb) at the American College of Gastroenterology 2024 Annual Scientific Meeting
Hand-out
Press Releases
Celltrion USA  
October 29, 2024

Celltrion presents post hoc analysis of LIBERTY studies of ZYMFENTRA®â€¯ (infliximab-dyyb) at the American College of Gastroenterology 2024 Annual Scientific Meeting

Pivotal LIBERTY studies (LIBERTY-CD and LIBERTY-UC) previously demonstrated superior efficacy of subcutaneous (SC) infliximab over placebo for maintenance therapy in patients with Crohn's disease (CD) and ulcerative colitis (UC)[1], [2]ZYMFENTRA®

avatar profile Olean Times Herald

Olean Times Herald


Local & Social